When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 14 Mar 2025
Last updated: 03 May 2022

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • fatigue
  • anorexia
  • weight loss
  • hyperpigmentation
  • acute circulatory collapse with hypotension and tachycardia
  • salt craving

Other diagnostic factors

  • gastrointestinal symptoms (nausea, vomiting, abdominal pain)
  • postural hypotension
  • arthralgia and myalgia
  • axillary and pubic hair loss in women

Risk factors

  • female sex
  • adrenocortical autoantibodies
  • adrenal haemorrhage
  • autoimmune diseases
  • coeliac disease
  • tuberculosis (TB)
  • non-TB bacterial infection
  • fungal infection
  • HIV
  • drugs that inhibit cortisol production
  • metastatic malignancy
  • sarcoidosis

Diagnostic investigations

1st investigations to order

  • morning serum cortisol
  • plasma adrenocorticotrophic hormone (ACTH)
  • serum electrolytes
  • urea and creatinine
  • FBC

Investigations to consider

  • adrenocorticotrophic hormone (ACTH) stimulation test
  • plasma renin activity
  • serum aldosterone
  • serum dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEA-S)
  • adrenal antibodies
  • adrenal CT or MRI
  • insulin hypoglycaemia test
  • overnight single-dose metyrapone test

Treatment algorithm

Contributors

Authors

Laleh Razavi Nematollahi, MD

Assistant Professor of Medicine

Division of Clinical and Molecular Endocrinology and Metabolism

University Hospitals Cleveland Medical Center

Case Western Reserve University

Cleveland

OH

Disclosures

LRN declares that she has no competing interests.

Baha Arafah, MD

Chief, Division of Endocrinology

University Hospitals Cleveland Medical Center

Case Western Reserve University

Cleveland

OH

Disclosures

BA declares that he has no competing interests.

Acknowledgements

Dr Laleh Razavi Nematollahi and Dr Baha Arafah would like to gratefully acknowledge Dr T. Joseph McKenna, Dr Shehzad Basaria, and Dr Milena Braga-Basaria, previous contributors to this topic.

Disclosures

TJM, SB, and MBB declare that they have no competing interests.

Peer reviewers

Rajesh K. Garg, MD

Instructor in Medicine

Brigham and Women's Hospital

Division of Endocrinology

Diabetes and Hypertension

Boston

MA

Disclosures

RKG declares that he has no competing interests.

Antoine Tabarin, MD

Head

Department of Endocrinology

Centre Hospitalier Universitaire de Bordeaux

Pessac

France

Disclosures

AT declares that he has no competing interests.

Blandine Gatta-Cherifi, MD

Department of Endocrinology

Centre Hospitalier Universitaire de Bordeaux

Pessac

France

Disclosures

BGC declares that she has no competing interests.

Use of this content is subject to our disclaimer